Medication

Mark A. Smith, MD, PhD, Chief Medical Officer, VistaGen Therapeutics, Inc

This blog post is presented by the ADAA 2020 Conference Gold Sponsor VistaGen Therapeutics.

Beth Salcedo, MD

Updated October 2020